AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
0-14|0.3|0.4|0.3|194|Mortality|59955368|Acute Lymphocytic|1999
0-14|3.4|3.7|3.5|2061|Incidence|58588724|Acute Lymphocytic|1999
0-14|0.2|0.3|0.2|141|Mortality|59955368|Acute Myeloid|1999
0-14|0.6|0.8|0.7|398|Incidence|58588724|Acute Myeloid|1999
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Cancer Sites Combined|1999
0-14|14.2|14.9|14.5|8502|Incidence|58588724|All Cancer Sites Combined|1999
0-14|0.1|0.2|0.1|82|Mortality|59955368|Bones and Joints|1999
0-14|0.7|0.8|0.7|432|Incidence|58588724|Bones and Joints|1999
0-14|0.7|0.8|0.7|431|Mortality|59955368|Brain and Other Nervous System|1999
0-14|3.1|3.4|3.3|1914|Incidence|58588724|Brain and Other Nervous System|1999
0-14|~|~|~|~|Mortality|59955368|Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|320|Incidence|58588724|Hodgkin Lymphoma|1999
0-14|0.1|0.1|0.1|54|Mortality|59955368|Kidney and Renal Pelvis|1999
0-14|0.8|0.9|0.8|487|Incidence|58588724|Kidney and Renal Pelvis|1999
0-14|0.7|0.8|0.8|451|Mortality|59955368|Leukemia|1999
0-14|4.4|4.7|4.5|2646|Incidence|58588724|Leukemia|1999
0-14|0.1|0.1|0.1|55|Mortality|59955368|Non-Hodgkin Lymphoma|1999
0-14|0.8|1.0|0.9|521|Incidence|58588724|Non-Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|328|Mortality|59955368|Other|1999
0-14|2.8|3.1|2.9|1693|Incidence|58588724|Other|1999
0-14|0.1|0.2|0.1|87|Mortality|59955368|Soft Tissue|1999
0-14|0.8|0.9|0.8|489|Incidence|58588724|Soft Tissue|1999
0-19|0.3|0.4|0.4|285|Mortality|80039970|Acute Lymphocytic|1999
0-19|2.9|3.1|3.0|2326|Incidence|78174581|Acute Lymphocytic|1999
0-19|0.2|0.3|0.3|207|Mortality|80039970|Acute Myeloid|1999
0-19|0.7|0.8|0.7|569|Incidence|78174581|Acute Myeloid|1999
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Cancer Sites Combined|1999
0-19|15.6|16.1|15.9|12377|Incidence|78174581|All Cancer Sites Combined|1999
0-19|0.2|0.3|0.3|209|Mortality|80039970|Bones and Joints|1999
0-19|0.8|1.0|0.9|707|Incidence|78174581|Bones and Joints|1999
0-19|0.6|0.7|0.7|546|Mortality|80039970|Brain and Other Nervous System|1999
0-19|2.8|3.1|3.0|2313|Incidence|78174581|Brain and Other Nervous System|1999
0-19|0.0|0.1|0.1|41|Mortality|80039970|Hodgkin Lymphoma|1999
0-19|1.1|1.3|1.2|924|Incidence|78174581|Hodgkin Lymphoma|1999
0-19|0.1|0.1|0.1|62|Mortality|80039970|Kidney and Renal Pelvis|1999
0-19|0.6|0.7|0.7|516|Incidence|78174581|Kidney and Renal Pelvis|1999
0-19|0.8|0.9|0.8|672|Mortality|80039970|Leukemia|1999
0-19|3.9|4.2|4.1|3170|Incidence|78174581|Leukemia|1999
0-19|0.1|0.2|0.1|106|Mortality|80039970|Non-Hodgkin Lymphoma|1999
0-19|1.0|1.1|1.1|827|Incidence|78174581|Non-Hodgkin Lymphoma|1999
0-19|0.5|0.6|0.6|455|Mortality|80039970|Other|1999
0-19|4.0|4.3|4.2|3234|Incidence|78174581|Other|1999
0-19|0.2|0.2|0.2|152|Mortality|80039970|Soft Tissue|1999
0-19|0.8|0.9|0.9|686|Incidence|78174581|Soft Tissue|1999
0-14|0.3|0.4|0.4|234|Mortality|60279841|Acute Lymphocytic|2000
0-14|3.5|3.8|3.7|2147|Incidence|58914904|Acute Lymphocytic|2000
0-14|0.2|0.3|0.2|145|Mortality|60279841|Acute Myeloid|2000
0-14|0.5|0.7|0.6|349|Incidence|58914904|Acute Myeloid|2000
0-14|2.4|2.7|2.5|1526|Mortality|60279841|All Cancer Sites Combined|2000
0-14|14.7|15.3|15.0|8814|Incidence|58914904|All Cancer Sites Combined|2000
0-14|0.1|0.2|0.1|83|Mortality|60279841|Bones and Joints|2000
0-14|0.6|0.7|0.7|399|Incidence|58914904|Bones and Joints|2000
0-14|0.7|0.8|0.7|440|Mortality|60279841|Brain and Other Nervous System|2000
0-14|3.3|3.6|3.4|2025|Incidence|58914904|Brain and Other Nervous System|2000
0-14|~|~|~|~|Mortality|60279841|Hodgkin Lymphoma|2000
0-14|0.5|0.6|0.6|345|Incidence|58914904|Hodgkin Lymphoma|2000
0-14|0.1|0.1|0.1|46|Mortality|60279841|Kidney and Renal Pelvis|2000
0-14|0.8|1.0|0.9|526|Incidence|58914904|Kidney and Renal Pelvis|2000
0-14|0.7|0.9|0.8|490|Mortality|60279841|Leukemia|2000
0-14|4.4|4.8|4.6|2695|Incidence|58914904|Leukemia|2000
0-14|0.1|0.1|0.1|55|Mortality|60279841|Non-Hodgkin Lymphoma|2000
0-14|0.9|1.0|0.9|553|Incidence|58914904|Non-Hodgkin Lymphoma|2000
0-14|0.5|0.6|0.6|333|Mortality|60279841|Other|2000
0-14|2.8|3.1|2.9|1710|Incidence|58914904|Other|2000
0-14|0.1|0.1|0.1|71|Mortality|60279841|Soft Tissue|2000
0-14|0.9|1.0|1.0|561|Incidence|58914904|Soft Tissue|2000
0-19|0.4|0.5|0.4|332|Mortality|80574796|Acute Lymphocytic|2000
0-19|3.0|3.3|3.1|2466|Incidence|78714159|Acute Lymphocytic|2000
0-19|0.2|0.3|0.3|222|Mortality|80574796|Acute Myeloid|2000
0-19|0.6|0.7|0.7|516|Incidence|78714159|Acute Myeloid|2000
0-19|2.7|2.9|2.8|2271|Mortality|80574796|All Cancer Sites Combined|2000
0-19|16.1|16.7|16.4|12887|Incidence|78714159|All Cancer Sites Combined|2000
0-19|0.2|0.3|0.2|181|Mortality|80574796|Bones and Joints|2000
0-19|0.8|0.9|0.9|673|Incidence|78714159|Bones and Joints|2000
0-19|0.6|0.7|0.7|545|Mortality|80574796|Brain and Other Nervous System|2000
0-19|3.0|3.3|3.1|2459|Incidence|78714159|Brain and Other Nervous System|2000
0-19|0.0|0.1|0.0|29|Mortality|80574796|Hodgkin Lymphoma|2000
0-19|1.2|1.3|1.2|970|Incidence|78714159|Hodgkin Lymphoma|2000
0-19|0.1|0.1|0.1|54|Mortality|80574796|Kidney and Renal Pelvis|2000
0-19|0.6|0.8|0.7|553|Incidence|78714159|Kidney and Renal Pelvis|2000
0-19|0.8|1.0|0.9|732|Mortality|80574796|Leukemia|2000
0-19|4.0|4.3|4.1|3242|Incidence|78714159|Leukemia|2000
0-19|0.1|0.2|0.1|115|Mortality|80574796|Non-Hodgkin Lymphoma|2000
0-19|1.1|1.2|1.1|901|Incidence|78714159|Non-Hodgkin Lymphoma|2000
0-19|0.5|0.6|0.6|471|Mortality|80574796|Other|2000
0-19|4.0|4.3|4.2|3283|Incidence|78714159|Other|2000
0-19|0.2|0.2|0.2|144|Mortality|80574796|Soft Tissue|2000
0-19|1.0|1.1|1.0|806|Incidence|78714159|Soft Tissue|2000
0-14|0.3|0.4|0.3|208|Mortality|60450257|Acute Lymphocytic|2001
0-14|3.6|4.0|3.8|2256|Incidence|59815030|Acute Lymphocytic|2001
0-14|0.2|0.3|0.3|157|Mortality|60450257|Acute Myeloid|2001
0-14|0.6|0.7|0.7|398|Incidence|59815030|Acute Myeloid|2001
0-14|2.4|2.6|2.5|1494|Mortality|60450257|All Cancer Sites Combined|2001
0-14|15.3|15.9|15.6|9331|Incidence|59815030|All Cancer Sites Combined|2001
0-14|0.1|0.2|0.1|88|Mortality|60450257|Bones and Joints|2001
0-14|0.6|0.8|0.7|432|Incidence|59815030|Bones and Joints|2001
0-14|0.6|0.8|0.7|416|Mortality|60450257|Brain and Other Nervous System|2001
0-14|3.2|3.5|3.4|2000|Incidence|59815030|Brain and Other Nervous System|2001
0-14|~|~|~|~|Mortality|60450257|Hodgkin Lymphoma|2001
0-14|0.5|0.7|0.6|357|Incidence|59815030|Hodgkin Lymphoma|2001
0-14|0.1|0.1|0.1|58|Mortality|60450257|Kidney and Renal Pelvis|2001
0-14|0.8|1.0|0.9|526|Incidence|59815030|Kidney and Renal Pelvis|2001
0-14|0.8|0.9|0.8|503|Mortality|60450257|Leukemia|2001
0-14|4.7|5.0|4.9|2887|Incidence|59815030|Leukemia|2001
0-14|0.0|0.1|0.1|40|Mortality|60450257|Non-Hodgkin Lymphoma|2001
0-14|0.8|1.0|0.9|544|Incidence|59815030|Non-Hodgkin Lymphoma|2001
0-14|0.4|0.6|0.5|297|Mortality|60450257|Other|2001
0-14|3.2|3.5|3.3|2001|Incidence|59815030|Other|2001
0-14|0.1|0.2|0.1|86|Mortality|60450257|Soft Tissue|2001
0-14|0.9|1.1|1.0|584|Incidence|59815030|Soft Tissue|2001
0-19|0.3|0.4|0.4|313|Mortality|80906541|Acute Lymphocytic|2001
0-19|3.1|3.4|3.2|2562|Incidence|80042731|Acute Lymphocytic|2001
0-19|0.2|0.3|0.3|227|Mortality|80906541|Acute Myeloid|2001
0-19|0.7|0.8|0.7|571|Incidence|80042731|Acute Myeloid|2001
0-19|2.6|2.9|2.8|2226|Mortality|80906541|All Cancer Sites Combined|2001
0-19|16.8|17.3|17.0|13641|Incidence|80042731|All Cancer Sites Combined|2001
0-19|0.2|0.3|0.2|189|Mortality|80906541|Bones and Joints|2001
0-19|0.9|1.0|1.0|779|Incidence|80042731|Bones and Joints|2001
0-19|0.6|0.7|0.6|520|Mortality|80906541|Brain and Other Nervous System|2001
0-19|2.9|3.2|3.0|2436|Incidence|80042731|Brain and Other Nervous System|2001
0-19|0.0|0.1|0.0|31|Mortality|80906541|Hodgkin Lymphoma|2001
0-19|1.2|1.3|1.3|1007|Incidence|80042731|Hodgkin Lymphoma|2001
0-19|0.1|0.1|0.1|66|Mortality|80906541|Kidney and Renal Pelvis|2001
0-19|0.6|0.8|0.7|559|Incidence|80042731|Kidney and Renal Pelvis|2001
0-19|0.8|1.0|0.9|728|Mortality|80906541|Leukemia|2001
0-19|4.2|4.5|4.4|3464|Incidence|80042731|Leukemia|2001
0-19|0.1|0.2|0.1|101|Mortality|80906541|Non-Hodgkin Lymphoma|2001
0-19|1.1|1.2|1.1|901|Incidence|80042731|Non-Hodgkin Lymphoma|2001
0-19|0.5|0.6|0.6|444|Mortality|80906541|Other|2001
0-19|4.4|4.7|4.6|3686|Incidence|80042731|Other|2001
0-19|0.2|0.2|0.2|147|Mortality|80906541|Soft Tissue|2001
0-19|0.9|1.1|1.0|809|Incidence|80042731|Soft Tissue|2001
0-14|0.3|0.4|0.4|217|Mortality|60563030|Acute Lymphocytic|2002
0-14|3.5|3.8|3.7|2174|Incidence|59931314|Acute Lymphocytic|2002
0-14|0.2|0.3|0.2|131|Mortality|60563030|Acute Myeloid|2002
0-14|0.6|0.7|0.7|407|Incidence|59931314|Acute Myeloid|2002
0-14|2.4|2.7|2.6|1548|Mortality|60563030|All Cancer Sites Combined|2002
0-14|15.2|15.8|15.5|9300|Incidence|59931314|All Cancer Sites Combined|2002
0-14|0.1|0.2|0.1|85|Mortality|60563030|Bones and Joints|2002
0-14|0.6|0.8|0.7|430|Incidence|59931314|Bones and Joints|2002
0-14|0.7|0.8|0.8|463|Mortality|60563030|Brain and Other Nervous System|2002
0-14|3.4|3.7|3.5|2114|Incidence|59931314|Brain and Other Nervous System|2002
0-14|~|~|~|~|Mortality|60563030|Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.6|336|Incidence|59931314|Hodgkin Lymphoma|2002
0-14|0.1|0.1|0.1|42|Mortality|60563030|Kidney and Renal Pelvis|2002
0-14|0.8|0.9|0.9|509|Incidence|59931314|Kidney and Renal Pelvis|2002
0-14|0.7|0.8|0.7|441|Mortality|60563030|Leukemia|2002
0-14|4.6|4.9|4.7|2832|Incidence|59931314|Leukemia|2002
0-14|0.1|0.2|0.1|74|Mortality|60563030|Non-Hodgkin Lymphoma|2002
0-14|0.8|1.0|0.9|541|Incidence|59931314|Non-Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.6|342|Mortality|60563030|Other|2002
0-14|3.1|3.4|3.2|1934|Incidence|59931314|Other|2002
0-14|0.1|0.2|0.2|95|Mortality|60563030|Soft Tissue|2002
0-14|0.9|1.1|1.0|604|Incidence|59931314|Soft Tissue|2002
0-19|0.4|0.4|0.4|323|Mortality|81173400|Acute Lymphocytic|2002
0-19|3.0|3.3|3.1|2502|Incidence|80317363|Acute Lymphocytic|2002
0-19|0.2|0.3|0.3|209|Mortality|81173400|Acute Myeloid|2002
0-19|0.7|0.8|0.7|575|Incidence|80317363|Acute Myeloid|2002
0-19|2.7|2.9|2.8|2271|Mortality|81173400|All Cancer Sites Combined|2002
0-19|16.8|17.4|17.1|13730|Incidence|80317363|All Cancer Sites Combined|2002
0-19|0.2|0.3|0.2|179|Mortality|81173400|Bones and Joints|2002
0-19|0.9|1.0|0.9|759|Incidence|80317363|Bones and Joints|2002
0-19|0.7|0.8|0.7|571|Mortality|81173400|Brain and Other Nervous System|2002
0-19|3.1|3.3|3.2|2566|Incidence|80317363|Brain and Other Nervous System|2002
0-19|0.0|0.1|0.0|33|Mortality|81173400|Hodgkin Lymphoma|2002
0-19|1.2|1.3|1.2|1005|Incidence|80317363|Hodgkin Lymphoma|2002
0-19|0.0|0.1|0.1|49|Mortality|81173400|Kidney and Renal Pelvis|2002
0-19|0.6|0.7|0.7|537|Incidence|80317363|Kidney and Renal Pelvis|2002
0-19|0.8|0.9|0.8|678|Mortality|81173400|Leukemia|2002
0-19|4.1|4.4|4.3|3407|Incidence|80317363|Leukemia|2002
0-19|0.1|0.2|0.1|118|Mortality|81173400|Non-Hodgkin Lymphoma|2002
0-19|1.1|1.2|1.1|911|Incidence|80317363|Non-Hodgkin Lymphoma|2002
0-19|0.6|0.7|0.6|490|Mortality|81173400|Other|2002
0-19|4.5|4.8|4.6|3721|Incidence|80317363|Other|2002
0-19|0.2|0.2|0.2|153|Mortality|81173400|Soft Tissue|2002
0-19|1.0|1.1|1.0|824|Incidence|80317363|Soft Tissue|2002
0-14|0.4|0.5|0.4|246|Mortality|60628650|Acute Lymphocytic|2003
0-14|3.4|3.7|3.6|2151|Incidence|60628650|Acute Lymphocytic|2003
0-14|0.2|0.3|0.2|142|Mortality|60628650|Acute Myeloid|2003
0-14|0.6|0.7|0.7|397|Incidence|60628650|Acute Myeloid|2003
0-14|2.4|2.7|2.5|1543|Mortality|60628650|All Cancer Sites Combined|2003
0-14|14.9|15.5|15.2|9251|Incidence|60628650|All Cancer Sites Combined|2003
0-14|0.1|0.2|0.1|82|Mortality|60628650|Bones and Joints|2003
0-14|0.6|0.8|0.7|420|Incidence|60628650|Bones and Joints|2003
0-14|0.7|0.8|0.8|458|Mortality|60628650|Brain and Other Nervous System|2003
0-14|3.2|3.5|3.4|2030|Incidence|60628650|Brain and Other Nervous System|2003
0-14|~|~|~|~|Mortality|60628650|Hodgkin Lymphoma|2003
0-14|0.5|0.7|0.6|362|Incidence|60628650|Hodgkin Lymphoma|2003
0-14|0.1|0.1|0.1|54|Mortality|60628650|Kidney and Renal Pelvis|2003
0-14|0.8|1.0|0.9|527|Incidence|60628650|Kidney and Renal Pelvis|2003
0-14|0.8|0.9|0.8|505|Mortality|60628650|Leukemia|2003
0-14|4.4|4.7|4.6|2752|Incidence|60628650|Leukemia|2003
0-14|0.1|0.1|0.1|50|Mortality|60628650|Non-Hodgkin Lymphoma|2003
0-14|0.8|1.0|0.9|548|Incidence|60628650|Non-Hodgkin Lymphoma|2003
0-14|0.5|0.6|0.5|311|Mortality|60628650|Other|2003
0-14|3.2|3.5|3.3|2030|Incidence|60628650|Other|2003
0-14|0.1|0.2|0.1|78|Mortality|60628650|Soft Tissue|2003
0-14|0.9|1.0|1.0|582|Incidence|60628650|Soft Tissue|2003
0-19|0.4|0.4|0.4|328|Mortality|81425816|Acute Lymphocytic|2003
0-19|2.9|3.2|3.0|2452|Incidence|81425816|Acute Lymphocytic|2003
0-19|0.2|0.3|0.3|207|Mortality|81425816|Acute Myeloid|2003
0-19|0.6|0.7|0.7|565|Incidence|81425816|Acute Myeloid|2003
0-19|2.6|2.9|2.7|2233|Mortality|81425816|All Cancer Sites Combined|2003
0-19|16.5|17.1|16.8|13701|Incidence|81425816|All Cancer Sites Combined|2003
0-19|0.2|0.3|0.2|186|Mortality|81425816|Bones and Joints|2003
0-19|0.8|1.0|0.9|732|Incidence|81425816|Bones and Joints|2003
0-19|0.7|0.8|0.7|577|Mortality|81425816|Brain and Other Nervous System|2003
0-19|3.0|3.2|3.1|2496|Incidence|81425816|Brain and Other Nervous System|2003
0-19|0.0|0.0|0.0|21|Mortality|81425816|Hodgkin Lymphoma|2003
0-19|1.2|1.3|1.2|1026|Incidence|81425816|Hodgkin Lymphoma|2003
0-19|0.1|0.1|0.1|65|Mortality|81425816|Kidney and Renal Pelvis|2003
0-19|0.6|0.8|0.7|558|Incidence|81425816|Kidney and Renal Pelvis|2003
0-19|0.8|0.9|0.8|688|Mortality|81425816|Leukemia|2003
0-19|4.0|4.2|4.1|3320|Incidence|81425816|Leukemia|2003
0-19|0.1|0.2|0.1|103|Mortality|81425816|Non-Hodgkin Lymphoma|2003
0-19|1.0|1.2|1.1|882|Incidence|81425816|Non-Hodgkin Lymphoma|2003
0-19|0.5|0.6|0.6|447|Mortality|81425816|Other|2003
0-19|4.5|4.8|4.7|3852|Incidence|81425816|Other|2003
0-19|0.2|0.2|0.2|146|Mortality|81425816|Soft Tissue|2003
0-19|1.0|1.1|1.0|835|Incidence|81425816|Soft Tissue|2003
0-14|0.3|0.4|0.3|202|Mortality|60651802|Acute Lymphocytic|2004
0-14|3.7|4.0|3.9|2333|Incidence|60651802|Acute Lymphocytic|2004
0-14|0.2|0.3|0.2|147|Mortality|60651802|Acute Myeloid|2004
0-14|0.6|0.8|0.7|423|Incidence|60651802|Acute Myeloid|2004
0-14|2.3|2.6|2.5|1492|Mortality|60651802|All Cancer Sites Combined|2004
0-14|15.7|16.3|16.0|9737|Incidence|60651802|All Cancer Sites Combined|2004
0-14|0.1|0.2|0.1|75|Mortality|60651802|Bones and Joints|2004
0-14|0.7|0.8|0.7|453|Incidence|60651802|Bones and Joints|2004
0-14|0.7|0.8|0.7|446|Mortality|60651802|Brain and Other Nervous System|2004
0-14|3.4|3.7|3.6|2175|Incidence|60651802|Brain and Other Nervous System|2004
0-14|~|~|~|~|Mortality|60651802|Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|324|Incidence|60651802|Hodgkin Lymphoma|2004
0-14|0.1|0.1|0.1|51|Mortality|60651802|Kidney and Renal Pelvis|2004
0-14|0.8|0.9|0.8|508|Incidence|60651802|Kidney and Renal Pelvis|2004
0-14|0.7|0.8|0.8|455|Mortality|60651802|Leukemia|2004
0-14|4.8|5.1|4.9|3000|Incidence|60651802|Leukemia|2004
0-14|0.1|0.1|0.1|44|Mortality|60651802|Non-Hodgkin Lymphoma|2004
0-14|0.9|1.0|0.9|574|Incidence|60651802|Non-Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|317|Mortality|60651802|Other|2004
0-14|3.3|3.6|3.4|2096|Incidence|60651802|Other|2004
0-14|0.1|0.2|0.2|98|Mortality|60651802|Soft Tissue|2004
0-14|0.9|1.1|1.0|607|Incidence|60651802|Soft Tissue|2004
0-19|0.3|0.4|0.4|295|Mortality|81754354|Acute Lymphocytic|2004
0-19|3.2|3.4|3.3|2676|Incidence|81754354|Acute Lymphocytic|2004
0-19|0.2|0.3|0.3|211|Mortality|81754354|Acute Myeloid|2004
0-19|0.7|0.8|0.7|597|Incidence|81754354|Acute Myeloid|2004
0-19|2.6|2.8|2.7|2223|Mortality|81754354|All Cancer Sites Combined|2004
0-19|17.1|17.7|17.4|14321|Incidence|81754354|All Cancer Sites Combined|2004
0-19|0.2|0.3|0.2|189|Mortality|81754354|Bones and Joints|2004
0-19|0.9|1.0|0.9|772|Incidence|81754354|Bones and Joints|2004
0-19|0.6|0.7|0.7|555|Mortality|81754354|Brain and Other Nervous System|2004
0-19|3.2|3.4|3.3|2670|Incidence|81754354|Brain and Other Nervous System|2004
0-19|0.0|0.0|0.0|23|Mortality|81754354|Hodgkin Lymphoma|2004
0-19|1.1|1.3|1.2|990|Incidence|81754354|Hodgkin Lymphoma|2004
0-19|0.1|0.1|0.1|59|Mortality|81754354|Kidney and Renal Pelvis|2004
0-19|0.6|0.7|0.7|550|Incidence|81754354|Kidney and Renal Pelvis|2004
0-19|0.8|0.9|0.8|665|Mortality|81754354|Leukemia|2004
0-19|4.3|4.6|4.4|3604|Incidence|81754354|Leukemia|2004
0-19|0.1|0.1|0.1|100|Mortality|81754354|Non-Hodgkin Lymphoma|2004
0-19|1.0|1.2|1.1|920|Incidence|81754354|Non-Hodgkin Lymphoma|2004
0-19|0.5|0.6|0.6|468|Mortality|81754354|Other|2004
0-19|4.6|4.9|4.8|3958|Incidence|81754354|Other|2004
0-19|0.2|0.2|0.2|164|Mortality|81754354|Soft Tissue|2004
0-19|1.0|1.1|1.0|857|Incidence|81754354|Soft Tissue|2004
0-14|0.3|0.4|0.3|188|Mortality|60519046|Acute Lymphocytic|2005
0-14|3.6|3.9|3.7|2261|Incidence|60519046|Acute Lymphocytic|2005
0-14|0.2|0.3|0.2|137|Mortality|60519046|Acute Myeloid|2005
0-14|0.6|0.7|0.6|390|Incidence|60519046|Acute Myeloid|2005
0-14|2.3|2.5|2.4|1452|Mortality|60519046|All Cancer Sites Combined|2005
0-14|15.3|15.9|15.6|9493|Incidence|60519046|All Cancer Sites Combined|2005
0-14|0.1|0.2|0.1|88|Mortality|60519046|Bones and Joints|2005
0-14|0.6|0.8|0.7|423|Incidence|60519046|Bones and Joints|2005
0-14|0.6|0.8|0.7|426|Mortality|60519046|Brain and Other Nervous System|2005
0-14|3.3|3.6|3.4|2063|Incidence|60519046|Brain and Other Nervous System|2005
0-14|~|~|~|~|Mortality|60519046|Hodgkin Lymphoma|2005
0-14|0.5|0.7|0.6|360|Incidence|60519046|Hodgkin Lymphoma|2005
0-14|0.1|0.1|0.1|54|Mortality|60519046|Kidney and Renal Pelvis|2005
0-14|0.8|0.9|0.9|519|Incidence|60519046|Kidney and Renal Pelvis|2005
0-14|0.6|0.8|0.7|417|Mortality|60519046|Leukemia|2005
0-14|4.6|4.9|4.8|2891|Incidence|60519046|Leukemia|2005
0-14|0.1|0.1|0.1|55|Mortality|60519046|Non-Hodgkin Lymphoma|2005
0-14|0.8|1.0|0.9|555|Incidence|60519046|Non-Hodgkin Lymphoma|2005
0-14|0.5|0.6|0.5|318|Mortality|60519046|Other|2005
0-14|3.2|3.5|3.4|2075|Incidence|60519046|Other|2005
0-14|0.1|0.2|0.1|83|Mortality|60519046|Soft Tissue|2005
0-14|0.9|1.1|1.0|607|Incidence|60519046|Soft Tissue|2005
0-19|0.3|0.4|0.3|267|Mortality|82005260|Acute Lymphocytic|2005
0-19|3.1|3.3|3.2|2592|Incidence|82005260|Acute Lymphocytic|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Acute Myeloid|2005
0-19|0.6|0.7|0.7|544|Incidence|82005260|Acute Myeloid|2005
0-19|2.5|2.8|2.7|2183|Mortality|82005260|All Cancer Sites Combined|2005
0-19|17.0|17.6|17.3|14270|Incidence|82005260|All Cancer Sites Combined|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Bones and Joints|2005
0-19|0.8|1.0|0.9|752|Incidence|82005260|Bones and Joints|2005
0-19|0.6|0.7|0.7|544|Mortality|82005260|Brain and Other Nervous System|2005
0-19|3.0|3.2|3.1|2542|Incidence|82005260|Brain and Other Nervous System|2005
0-19|0.0|0.0|0.0|22|Mortality|82005260|Hodgkin Lymphoma|2005
0-19|1.2|1.3|1.3|1069|Incidence|82005260|Hodgkin Lymphoma|2005
0-19|0.1|0.1|0.1|62|Mortality|82005260|Kidney and Renal Pelvis|2005
0-19|0.6|0.8|0.7|568|Incidence|82005260|Kidney and Renal Pelvis|2005
0-19|0.7|0.8|0.8|640|Mortality|82005260|Leukemia|2005
0-19|4.1|4.4|4.3|3488|Incidence|82005260|Leukemia|2005
0-19|0.1|0.1|0.1|102|Mortality|82005260|Non-Hodgkin Lymphoma|2005
0-19|1.1|1.3|1.2|974|Incidence|82005260|Non-Hodgkin Lymphoma|2005
0-19|0.5|0.6|0.5|438|Mortality|82005260|Other|2005
0-19|4.7|5.0|4.8|4022|Incidence|82005260|Other|2005
0-19|0.2|0.2|0.2|163|Mortality|82005260|Soft Tissue|2005
0-19|1.0|1.1|1.0|855|Incidence|82005260|Soft Tissue|2005
0-14|0.2|0.3|0.3|174|Mortality|60516709|Acute Lymphocytic|2006
0-14|3.7|4.0|3.9|2351|Incidence|60516709|Acute Lymphocytic|2006
0-14|0.2|0.2|0.2|124|Mortality|60516709|Acute Myeloid|2006
0-14|0.6|0.8|0.7|421|Incidence|60516709|Acute Myeloid|2006
0-14|2.1|2.4|2.2|1360|Mortality|60516709|All Cancer Sites Combined|2006
0-14|15.6|16.2|15.9|9679|Incidence|60516709|All Cancer Sites Combined|2006
0-14|0.1|0.1|0.1|59|Mortality|60516709|Bones and Joints|2006
0-14|0.7|0.8|0.7|439|Incidence|60516709|Bones and Joints|2006
0-14|0.6|0.8|0.7|422|Mortality|60516709|Brain and Other Nervous System|2006
0-14|3.4|3.7|3.5|2121|Incidence|60516709|Brain and Other Nervous System|2006
0-14|~|~|~|~|Mortality|60516709|Hodgkin Lymphoma|2006
0-14|0.6|0.7|0.6|375|Incidence|60516709|Hodgkin Lymphoma|2006
0-14|0.1|0.1|0.1|43|Mortality|60516709|Kidney and Renal Pelvis|2006
0-14|0.8|0.9|0.9|525|Incidence|60516709|Kidney and Renal Pelvis|2006
0-14|0.6|0.7|0.7|411|Mortality|60516709|Leukemia|2006
0-14|4.8|5.1|5.0|3011|Incidence|60516709|Leukemia|2006
0-14|0.1|0.1|0.1|44|Mortality|60516709|Non-Hodgkin Lymphoma|2006
0-14|0.8|1.0|0.9|550|Incidence|60516709|Non-Hodgkin Lymphoma|2006
0-14|0.4|0.5|0.5|296|Mortality|60516709|Other|2006
0-14|3.2|3.5|3.4|2062|Incidence|60516709|Other|2006
0-14|0.1|0.2|0.1|80|Mortality|60516709|Soft Tissue|2006
0-14|0.9|1.1|1.0|596|Incidence|60516709|Soft Tissue|2006
0-19|0.3|0.4|0.3|266|Mortality|82324418|Acute Lymphocytic|2006
0-19|3.2|3.4|3.3|2710|Incidence|82324418|Acute Lymphocytic|2006
0-19|0.2|0.3|0.2|195|Mortality|82324418|Acute Myeloid|2006
0-19|0.7|0.8|0.7|598|Incidence|82324418|Acute Myeloid|2006
0-19|2.4|2.6|2.5|2035|Mortality|82324418|All Cancer Sites Combined|2006
0-19|17.0|17.6|17.3|14379|Incidence|82324418|All Cancer Sites Combined|2006
0-19|0.2|0.2|0.2|174|Mortality|82324418|Bones and Joints|2006
0-19|0.9|1.0|1.0|796|Incidence|82324418|Bones and Joints|2006
0-19|0.6|0.7|0.6|524|Mortality|82324418|Brain and Other Nervous System|2006
0-19|3.1|3.3|3.2|2630|Incidence|82324418|Brain and Other Nervous System|2006
0-19|0.0|0.0|0.0|23|Mortality|82324418|Hodgkin Lymphoma|2006
0-19|1.2|1.3|1.2|1058|Incidence|82324418|Hodgkin Lymphoma|2006
0-19|0.1|0.1|0.1|54|Mortality|82324418|Kidney and Renal Pelvis|2006
0-19|0.6|0.8|0.7|573|Incidence|82324418|Kidney and Renal Pelvis|2006
0-19|0.7|0.8|0.7|618|Mortality|82324418|Leukemia|2006
0-19|4.3|4.6|4.5|3667|Incidence|82324418|Leukemia|2006
0-19|0.1|0.1|0.1|89|Mortality|82324418|Non-Hodgkin Lymphoma|2006
0-19|1.1|1.2|1.1|943|Incidence|82324418|Non-Hodgkin Lymphoma|2006
0-19|0.5|0.6|0.5|413|Mortality|82324418|Other|2006
0-19|4.5|4.8|4.6|3886|Incidence|82324418|Other|2006
0-19|0.1|0.2|0.2|140|Mortality|82324418|Soft Tissue|2006
0-19|0.9|1.1|1.0|826|Incidence|82324418|Soft Tissue|2006
0-14|0.3|0.4|0.4|212|Mortality|60681615|Acute Lymphocytic|2007
0-14|3.8|4.1|4.0|2429|Incidence|60681615|Acute Lymphocytic|2007
0-14|0.2|0.3|0.2|129|Mortality|60681615|Acute Myeloid|2007
0-14|0.6|0.7|0.7|415|Incidence|60681615|Acute Myeloid|2007
0-14|2.2|2.4|2.3|1395|Mortality|60681615|All Cancer Sites Combined|2007
0-14|15.9|16.6|16.2|9923|Incidence|60681615|All Cancer Sites Combined|2007
0-14|0.1|0.1|0.1|61|Mortality|60681615|Bones and Joints|2007
0-14|0.6|0.8|0.7|427|Incidence|60681615|Bones and Joints|2007
0-14|0.6|0.8|0.7|426|Mortality|60681615|Brain and Other Nervous System|2007
0-14|3.5|3.8|3.6|2212|Incidence|60681615|Brain and Other Nervous System|2007
0-14|~|~|~|~|Mortality|60681615|Hodgkin Lymphoma|2007
0-14|0.5|0.6|0.5|332|Incidence|60681615|Hodgkin Lymphoma|2007
0-14|0.0|0.1|0.1|36|Mortality|60681615|Kidney and Renal Pelvis|2007
0-14|0.8|1.0|0.9|544|Incidence|60681615|Kidney and Renal Pelvis|2007
0-14|0.7|0.8|0.7|441|Mortality|60681615|Leukemia|2007
0-14|4.9|5.2|5.0|3070|Incidence|60681615|Leukemia|2007
0-14|0.0|0.1|0.1|40|Mortality|60681615|Non-Hodgkin Lymphoma|2007
0-14|0.9|1.1|1.0|596|Incidence|60681615|Non-Hodgkin Lymphoma|2007
0-14|0.4|0.6|0.5|306|Mortality|60681615|Other|2007
0-14|3.2|3.5|3.4|2090|Incidence|60681615|Other|2007
0-14|0.1|0.2|0.1|82|Mortality|60681615|Soft Tissue|2007
0-14|1.0|1.1|1.1|652|Incidence|60681615|Soft Tissue|2007
0-19|0.3|0.4|0.4|294|Mortality|82749431|Acute Lymphocytic|2007
0-19|3.3|3.5|3.4|2800|Incidence|82749431|Acute Lymphocytic|2007
0-19|0.2|0.3|0.2|195|Mortality|82749431|Acute Myeloid|2007
0-19|0.6|0.8|0.7|585|Incidence|82749431|Acute Myeloid|2007
0-19|2.4|2.6|2.5|2068|Mortality|82749431|All Cancer Sites Combined|2007
0-19|17.4|18.0|17.7|14805|Incidence|82749431|All Cancer Sites Combined|2007
0-19|0.2|0.2|0.2|172|Mortality|82749431|Bones and Joints|2007
0-19|0.8|1.0|0.9|753|Incidence|82749431|Bones and Joints|2007
0-19|0.6|0.7|0.6|521|Mortality|82749431|Brain and Other Nervous System|2007
0-19|3.2|3.4|3.3|2712|Incidence|82749431|Brain and Other Nervous System|2007
0-19|0.0|0.0|0.0|19|Mortality|82749431|Hodgkin Lymphoma|2007
0-19|1.1|1.3|1.2|1038|Incidence|82749431|Hodgkin Lymphoma|2007
0-19|0.0|0.1|0.1|47|Mortality|82749431|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.7|587|Incidence|82749431|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.8|643|Mortality|82749431|Leukemia|2007
0-19|4.4|4.7|4.5|3722|Incidence|82749431|Leukemia|2007
0-19|0.1|0.1|0.1|87|Mortality|82749431|Non-Hodgkin Lymphoma|2007
0-19|1.1|1.2|1.2|977|Incidence|82749431|Non-Hodgkin Lymphoma|2007
0-19|0.5|0.6|0.5|439|Mortality|82749431|Other|2007
0-19|4.7|5.0|4.8|4094|Incidence|82749431|Other|2007
0-19|0.1|0.2|0.2|140|Mortality|82749431|Soft Tissue|2007
0-19|1.0|1.2|1.1|922|Incidence|82749431|Soft Tissue|2007
0-14|0.2|0.3|0.3|176|Mortality|60907384|Acute Lymphocytic|2008
0-14|3.9|4.3|4.1|2508|Incidence|60907384|Acute Lymphocytic|2008
0-14|0.2|0.2|0.2|127|Mortality|60907384|Acute Myeloid|2008
0-14|0.6|0.8|0.7|436|Incidence|60907384|Acute Myeloid|2008
0-14|2.1|2.3|2.2|1354|Mortality|60907384|All Cancer Sites Combined|2008
0-14|16.2|16.8|16.5|10132|Incidence|60907384|All Cancer Sites Combined|2008
0-14|0.1|0.1|0.1|62|Mortality|60907384|Bones and Joints|2008
0-14|0.6|0.8|0.7|426|Incidence|60907384|Bones and Joints|2008
0-14|0.6|0.8|0.7|429|Mortality|60907384|Brain and Other Nervous System|2008
0-14|3.5|3.8|3.7|2231|Incidence|60907384|Brain and Other Nervous System|2008
0-14|~|~|~|~|Mortality|60907384|Hodgkin Lymphoma|2008
0-14|0.6|0.7|0.6|384|Incidence|60907384|Hodgkin Lymphoma|2008
0-14|0.1|0.1|0.1|46|Mortality|60907384|Kidney and Renal Pelvis|2008
0-14|0.8|1.0|0.9|571|Incidence|60907384|Kidney and Renal Pelvis|2008
0-14|0.6|0.7|0.7|402|Mortality|60907384|Leukemia|2008
0-14|5.0|5.3|5.2|3169|Incidence|60907384|Leukemia|2008
0-14|0.0|0.1|0.1|39|Mortality|60907384|Non-Hodgkin Lymphoma|2008
0-14|0.9|1.0|1.0|582|Incidence|60907384|Non-Hodgkin Lymphoma|2008
0-14|0.4|0.5|0.5|286|Mortality|60907384|Other|2008
0-14|3.2|3.5|3.4|2099|Incidence|60907384|Other|2008
0-14|0.1|0.2|0.1|89|Mortality|60907384|Soft Tissue|2008
0-14|1.0|1.2|1.1|670|Incidence|60907384|Soft Tissue|2008
0-19|0.3|0.3|0.3|253|Mortality|83118264|Acute Lymphocytic|2008
0-19|3.4|3.6|3.5|2884|Incidence|83118264|Acute Lymphocytic|2008
0-19|0.2|0.3|0.2|183|Mortality|83118264|Acute Myeloid|2008
0-19|0.7|0.8|0.7|629|Incidence|83118264|Acute Myeloid|2008
0-19|2.3|2.5|2.4|2039|Mortality|83118264|All Cancer Sites Combined|2008
0-19|17.6|18.2|17.9|15054|Incidence|83118264|All Cancer Sites Combined|2008
0-19|0.2|0.2|0.2|182|Mortality|83118264|Bones and Joints|2008
0-19|0.8|1.0|0.9|750|Incidence|83118264|Bones and Joints|2008
0-19|0.6|0.7|0.6|533|Mortality|83118264|Brain and Other Nervous System|2008
0-19|3.2|3.5|3.3|2754|Incidence|83118264|Brain and Other Nervous System|2008
0-19|~|~|~|~|Mortality|83118264|Hodgkin Lymphoma|2008
0-19|1.2|1.4|1.3|1107|Incidence|83118264|Hodgkin Lymphoma|2008
0-19|0.0|0.1|0.1|52|Mortality|83118264|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|620|Incidence|83118264|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|598|Mortality|83118264|Leukemia|2008
0-19|4.5|4.8|4.6|3847|Incidence|83118264|Leukemia|2008
0-19|0.1|0.1|0.1|93|Mortality|83118264|Non-Hodgkin Lymphoma|2008
0-19|1.1|1.2|1.2|969|Incidence|83118264|Non-Hodgkin Lymphoma|2008
0-19|0.4|0.5|0.5|407|Mortality|83118264|Other|2008
0-19|4.6|4.9|4.8|4091|Incidence|83118264|Other|2008
0-19|0.2|0.2|0.2|160|Mortality|83118264|Soft Tissue|2008
0-19|1.0|1.2|1.1|916|Incidence|83118264|Soft Tissue|2008
0-14|0.2|0.3|0.3|174|Mortality|61087581|Acute Lymphocytic|2009
0-14|3.9|4.3|4.1|2521|Incidence|61087581|Acute Lymphocytic|2009
0-14|0.2|0.2|0.2|119|Mortality|61087581|Acute Myeloid|2009
0-14|0.6|0.7|0.6|400|Incidence|61087581|Acute Myeloid|2009
0-14|2.0|2.3|2.2|1320|Mortality|61087581|All Cancer Sites Combined|2009
0-14|16.1|16.7|16.4|10057|Incidence|61087581|All Cancer Sites Combined|2009
0-14|0.1|0.2|0.1|77|Mortality|61087581|Bones and Joints|2009
0-14|0.7|0.8|0.7|434|Incidence|61087581|Bones and Joints|2009
0-14|0.6|0.7|0.7|402|Mortality|61087581|Brain and Other Nervous System|2009
0-14|3.5|3.8|3.6|2219|Incidence|61087581|Brain and Other Nervous System|2009
0-14|~|~|~|~|Mortality|61087581|Hodgkin Lymphoma|2009
0-14|0.5|0.6|0.6|349|Incidence|61087581|Hodgkin Lymphoma|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Kidney and Renal Pelvis|2009
0-14|0.9|1.0|1.0|592|Incidence|61087581|Kidney and Renal Pelvis|2009
0-14|0.6|0.7|0.6|389|Mortality|61087581|Leukemia|2009
0-14|4.9|5.3|5.1|3136|Incidence|61087581|Leukemia|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Non-Hodgkin Lymphoma|2009
0-14|0.9|1.0|0.9|577|Incidence|61087581|Non-Hodgkin Lymphoma|2009
0-14|0.4|0.5|0.4|271|Mortality|61087581|Other|2009
0-14|3.3|3.6|3.4|2107|Incidence|61087581|Other|2009
0-14|0.1|0.2|0.2|98|Mortality|61087581|Soft Tissue|2009
0-14|1.0|1.1|1.0|643|Incidence|61087581|Soft Tissue|2009
0-19|0.3|0.3|0.3|240|Mortality|83280391|Acute Lymphocytic|2009
0-19|3.3|3.6|3.5|2875|Incidence|83280391|Acute Lymphocytic|2009
0-19|0.2|0.3|0.2|182|Mortality|83280391|Acute Myeloid|2009
0-19|0.6|0.7|0.7|580|Incidence|83280391|Acute Myeloid|2009
0-19|2.2|2.5|2.3|1964|Mortality|83280391|All Cancer Sites Combined|2009
0-19|17.6|18.1|17.9|14997|Incidence|83280391|All Cancer Sites Combined|2009
0-19|0.2|0.2|0.2|179|Mortality|83280391|Bones and Joints|2009
0-19|0.9|1.0|0.9|768|Incidence|83280391|Bones and Joints|2009
0-19|0.6|0.7|0.6|522|Mortality|83280391|Brain and Other Nervous System|2009
0-19|3.2|3.4|3.3|2718|Incidence|83280391|Brain and Other Nervous System|2009
0-19|0.0|0.0|0.0|22|Mortality|83280391|Hodgkin Lymphoma|2009
0-19|1.2|1.3|1.3|1083|Incidence|83280391|Hodgkin Lymphoma|2009
0-19|0.0|0.1|0.1|45|Mortality|83280391|Kidney and Renal Pelvis|2009
0-19|0.7|0.8|0.8|637|Incidence|83280391|Kidney and Renal Pelvis|2009
0-19|0.6|0.7|0.7|561|Mortality|83280391|Leukemia|2009
0-19|4.4|4.7|4.5|3768|Incidence|83280391|Leukemia|2009
0-19|0.1|0.1|0.1|75|Mortality|83280391|Non-Hodgkin Lymphoma|2009
0-19|1.1|1.2|1.1|949|Incidence|83280391|Non-Hodgkin Lymphoma|2009
0-19|0.4|0.5|0.5|396|Mortality|83280391|Other|2009
0-19|4.7|5.0|4.9|4155|Incidence|83280391|Other|2009
0-19|0.2|0.2|0.2|164|Mortality|83280391|Soft Tissue|2009
0-19|1.0|1.2|1.1|919|Incidence|83280391|Soft Tissue|2009
0-14|0.2|0.3|0.3|164|Mortality|61200649|Acute Lymphocytic|2010
0-14|3.9|4.2|4.1|2513|Incidence|61200649|Acute Lymphocytic|2010
0-14|0.2|0.3|0.2|131|Mortality|61200649|Acute Myeloid|2010
0-14|0.6|0.8|0.7|433|Incidence|61200649|Acute Myeloid|2010
0-14|2.0|2.3|2.2|1324|Mortality|61200649|All Cancer Sites Combined|2010
0-14|16.8|17.4|17.1|10507|Incidence|61200649|All Cancer Sites Combined|2010
0-14|0.1|0.2|0.1|75|Mortality|61200649|Bones and Joints|2010
0-14|0.6|0.8|0.7|422|Incidence|61200649|Bones and Joints|2010
0-14|0.6|0.7|0.7|410|Mortality|61200649|Brain and Other Nervous System|2010
0-14|3.6|3.9|3.7|2299|Incidence|61200649|Brain and Other Nervous System|2010
0-14|~|~|~|~|Mortality|61200649|Hodgkin Lymphoma|2010
0-14|0.5|0.6|0.5|324|Incidence|61200649|Hodgkin Lymphoma|2010
0-14|0.1|0.1|0.1|46|Mortality|61200649|Kidney and Renal Pelvis|2010
0-14|0.8|1.0|0.9|543|Incidence|61200649|Kidney and Renal Pelvis|2010
0-14|0.6|0.7|0.6|390|Mortality|61200649|Leukemia|2010
0-14|5.0|5.3|5.1|3163|Incidence|61200649|Leukemia|2010
0-14|0.0|0.1|0.1|35|Mortality|61200649|Non-Hodgkin Lymphoma|2010
0-14|0.9|1.1|1.0|594|Incidence|61200649|Non-Hodgkin Lymphoma|2010
0-14|0.4|0.5|0.5|286|Mortality|61200649|Other|2010
0-14|3.9|4.2|4.1|2500|Incidence|61200649|Other|2010
0-14|0.1|0.2|0.1|79|Mortality|61200649|Soft Tissue|2010
0-14|1.0|1.2|1.1|662|Incidence|61200649|Soft Tissue|2010
0-19|0.2|0.3|0.3|230|Mortality|83181748|Acute Lymphocytic|2010
0-19|3.3|3.6|3.4|2847|Incidence|83181748|Acute Lymphocytic|2010
0-19|0.2|0.3|0.2|198|Mortality|83181748|Acute Myeloid|2010
0-19|0.7|0.8|0.8|634|Incidence|83181748|Acute Myeloid|2010
0-19|2.2|2.4|2.3|1925|Mortality|83181748|All Cancer Sites Combined|2010
0-19|18.0|18.5|18.3|15280|Incidence|83181748|All Cancer Sites Combined|2010
0-19|0.2|0.2|0.2|166|Mortality|83181748|Bones and Joints|2010
0-19|0.8|0.9|0.9|714|Incidence|83181748|Bones and Joints|2010
0-19|0.6|0.7|0.6|498|Mortality|83181748|Brain and Other Nervous System|2010
0-19|3.2|3.5|3.3|2776|Incidence|83181748|Brain and Other Nervous System|2010
0-19|~|~|~|~|Mortality|83181748|Hodgkin Lymphoma|2010
0-19|1.1|1.3|1.2|1035|Incidence|83181748|Hodgkin Lymphoma|2010
0-19|0.1|0.1|0.1|56|Mortality|83181748|Kidney and Renal Pelvis|2010
0-19|0.6|0.8|0.7|577|Incidence|83181748|Kidney and Renal Pelvis|2010
0-19|0.6|0.7|0.7|553|Mortality|83181748|Leukemia|2010
0-19|4.4|4.7|4.6|3806|Incidence|83181748|Leukemia|2010
0-19|0.1|0.1|0.1|75|Mortality|83181748|Non-Hodgkin Lymphoma|2010
0-19|1.1|1.2|1.1|950|Incidence|83181748|Non-Hodgkin Lymphoma|2010
0-19|0.5|0.6|0.5|419|Mortality|83181748|Other|2010
0-19|5.2|5.5|5.3|4511|Incidence|83181748|Other|2010
0-19|0.1|0.2|0.2|146|Mortality|83181748|Soft Tissue|2010
0-19|1.0|1.2|1.1|911|Incidence|83181748|Soft Tissue|2010
0-14|0.2|0.3|0.3|153|Mortality|61168399|Acute Lymphocytic|2011
0-14|4.0|4.3|4.2|2569|Incidence|61168399|Acute Lymphocytic|2011
0-14|0.2|0.2|0.2|117|Mortality|61168399|Acute Myeloid|2011
0-14|0.6|0.8|0.7|428|Incidence|61168399|Acute Myeloid|2011
0-14|2.0|2.2|2.1|1283|Mortality|61168399|All Cancer Sites Combined|2011
0-14|16.7|17.4|17.1|10476|Incidence|61168399|All Cancer Sites Combined|2011
0-14|0.1|0.2|0.1|73|Mortality|61168399|Bones and Joints|2011
0-14|0.7|0.8|0.8|466|Incidence|61168399|Bones and Joints|2011
0-14|0.7|0.8|0.7|439|Mortality|61168399|Brain and Other Nervous System|2011
0-14|3.5|3.8|3.7|2254|Incidence|61168399|Brain and Other Nervous System|2011
0-14|~|~|~|~|Mortality|61168399|Hodgkin Lymphoma|2011
0-14|0.5|0.6|0.5|316|Incidence|61168399|Hodgkin Lymphoma|2011
0-14|0.0|0.1|0.1|39|Mortality|61168399|Kidney and Renal Pelvis|2011
0-14|0.9|1.0|0.9|574|Incidence|61168399|Kidney and Renal Pelvis|2011
0-14|0.5|0.6|0.6|342|Mortality|61168399|Leukemia|2011
0-14|5.0|5.4|5.2|3205|Incidence|61168399|Leukemia|2011
0-14|0.0|0.1|0.1|32|Mortality|61168399|Non-Hodgkin Lymphoma|2011
0-14|0.8|1.0|0.9|561|Incidence|61168399|Non-Hodgkin Lymphoma|2011
0-14|0.4|0.5|0.4|273|Mortality|61168399|Other|2011
0-14|3.9|4.2|4.0|2480|Incidence|61168399|Other|2011
0-14|0.1|0.2|0.1|84|Mortality|61168399|Soft Tissue|2011
0-14|0.9|1.1|1.0|620|Incidence|61168399|Soft Tissue|2011
0-19|0.2|0.3|0.3|223|Mortality|82826880|Acute Lymphocytic|2011
0-19|3.4|3.7|3.6|2943|Incidence|82826880|Acute Lymphocytic|2011
0-19|0.2|0.2|0.2|174|Mortality|82826880|Acute Myeloid|2011
0-19|0.7|0.8|0.8|634|Incidence|82826880|Acute Myeloid|2011
0-19|2.2|2.4|2.3|1922|Mortality|82826880|All Cancer Sites Combined|2011
0-19|18.2|18.7|18.4|15364|Incidence|82826880|All Cancer Sites Combined|2011
0-19|0.2|0.2|0.2|174|Mortality|82826880|Bones and Joints|2011
0-19|0.9|1.0|0.9|761|Incidence|82826880|Bones and Joints|2011
0-19|0.6|0.7|0.7|550|Mortality|82826880|Brain and Other Nervous System|2011
0-19|3.3|3.5|3.4|2816|Incidence|82826880|Brain and Other Nervous System|2011
0-19|0.0|0.0|0.0|17|Mortality|82826880|Hodgkin Lymphoma|2011
0-19|1.1|1.3|1.2|1003|Incidence|82826880|Hodgkin Lymphoma|2011
0-19|0.0|0.1|0.1|45|Mortality|82826880|Kidney and Renal Pelvis|2011
0-19|0.7|0.8|0.7|618|Incidence|82826880|Kidney and Renal Pelvis|2011
0-19|0.6|0.7|0.6|519|Mortality|82826880|Leukemia|2011
0-19|4.5|4.8|4.7|3886|Incidence|82826880|Leukemia|2011
0-19|0.1|0.1|0.1|64|Mortality|82826880|Non-Hodgkin Lymphoma|2011
0-19|1.1|1.2|1.1|936|Incidence|82826880|Non-Hodgkin Lymphoma|2011
0-19|0.4|0.5|0.5|405|Mortality|82826880|Other|2011
0-19|5.2|5.5|5.4|4494|Incidence|82826880|Other|2011
0-19|0.1|0.2|0.2|148|Mortality|82826880|Soft Tissue|2011
0-19|1.0|1.1|1.0|850|Incidence|82826880|Soft Tissue|2011
0-14|0.2|0.3|0.2|152|Mortality|61112950|Acute Lymphocytic|2012
0-14|3.8|4.2|4.0|2459|Incidence|61112950|Acute Lymphocytic|2012
0-14|0.2|0.3|0.2|137|Mortality|61112950|Acute Myeloid|2012
0-14|0.6|0.7|0.6|398|Incidence|61112950|Acute Myeloid|2012
0-14|2.1|2.4|2.2|1367|Mortality|61112950|All Cancer Sites Combined|2012
0-14|16.7|17.3|17.0|10421|Incidence|61112950|All Cancer Sites Combined|2012
0-14|0.1|0.1|0.1|68|Mortality|61112950|Bones and Joints|2012
0-14|0.7|0.8|0.8|458|Incidence|61112950|Bones and Joints|2012
0-14|0.7|0.8|0.8|458|Mortality|61112950|Brain and Other Nervous System|2012
0-14|3.5|3.8|3.6|2226|Incidence|61112950|Brain and Other Nervous System|2012
0-14|~|~|~|~|Mortality|61112950|Hodgkin Lymphoma|2012
0-14|0.5|0.6|0.6|351|Incidence|61112950|Hodgkin Lymphoma|2012
0-14|0.0|0.1|0.0|30|Mortality|61112950|Kidney and Renal Pelvis|2012
0-14|0.8|1.0|0.9|545|Incidence|61112950|Kidney and Renal Pelvis|2012
0-14|0.6|0.7|0.6|378|Mortality|61112950|Leukemia|2012
0-14|4.8|5.2|5.0|3055|Incidence|61112950|Leukemia|2012
0-14|0.0|0.1|0.1|36|Mortality|61112950|Non-Hodgkin Lymphoma|2012
0-14|0.9|1.1|1.0|622|Incidence|61112950|Non-Hodgkin Lymphoma|2012
0-14|0.4|0.5|0.5|292|Mortality|61112950|Other|2012
0-14|4.0|4.3|4.1|2521|Incidence|61112950|Other|2012
0-14|0.1|0.2|0.2|101|Mortality|61112950|Soft Tissue|2012
0-14|1.0|1.1|1.1|643|Incidence|61112950|Soft Tissue|2012
0-19|0.2|0.3|0.3|219|Mortality|82482164|Acute Lymphocytic|2012
0-19|3.3|3.5|3.4|2788|Incidence|82482164|Acute Lymphocytic|2012
0-19|0.2|0.3|0.2|193|Mortality|82482164|Acute Myeloid|2012
0-19|0.7|0.8|0.7|596|Incidence|82482164|Acute Myeloid|2012
0-19|2.3|2.5|2.4|1995|Mortality|82482164|All Cancer Sites Combined|2012
0-19|18.3|18.9|18.6|15392|Incidence|82482164|All Cancer Sites Combined|2012
0-19|0.2|0.2|0.2|178|Mortality|82482164|Bones and Joints|2012
0-19|0.9|1.0|0.9|772|Incidence|82482164|Bones and Joints|2012
0-19|0.6|0.8|0.7|575|Mortality|82482164|Brain and Other Nervous System|2012
0-19|3.2|3.4|3.3|2729|Incidence|82482164|Brain and Other Nervous System|2012
0-19|~|~|~|~|Mortality|82482164|Hodgkin Lymphoma|2012
0-19|1.2|1.3|1.3|1051|Incidence|82482164|Hodgkin Lymphoma|2012
0-19|0.0|0.1|0.0|40|Mortality|82482164|Kidney and Renal Pelvis|2012
0-19|0.7|0.8|0.7|600|Incidence|82482164|Kidney and Renal Pelvis|2012
0-19|0.6|0.7|0.6|534|Mortality|82482164|Leukemia|2012
0-19|4.3|4.6|4.5|3694|Incidence|82482164|Leukemia|2012
0-19|0.1|0.1|0.1|60|Mortality|82482164|Non-Hodgkin Lymphoma|2012
0-19|1.2|1.3|1.3|1043|Incidence|82482164|Non-Hodgkin Lymphoma|2012
0-19|0.5|0.6|0.5|421|Mortality|82482164|Other|2012
0-19|5.4|5.7|5.6|4651|Incidence|82482164|Other|2012
0-19|0.2|0.2|0.2|177|Mortality|82482164|Soft Tissue|2012
0-19|1.0|1.1|1.0|852|Incidence|82482164|Soft Tissue|2012
0-14|0.2|0.3|0.2|141|Mortality|61067428|Acute Lymphocytic|2013
0-14|3.6|3.9|3.8|2308|Incidence|61067428|Acute Lymphocytic|2013
0-14|0.2|0.2|0.2|127|Mortality|61067428|Acute Myeloid|2013
0-14|0.7|0.8|0.7|438|Incidence|61067428|Acute Myeloid|2013
0-14|2.0|2.2|2.1|1287|Mortality|61067428|All Cancer Sites Combined|2013
0-14|16.9|17.6|17.3|10559|Incidence|61067428|All Cancer Sites Combined|2013
0-14|0.1|0.1|0.1|72|Mortality|61067428|Bones and Joints|2013
0-14|0.7|0.8|0.8|470|Incidence|61067428|Bones and Joints|2013
0-14|0.7|0.8|0.7|437|Mortality|61067428|Brain and Other Nervous System|2013
0-14|3.6|4.0|3.8|2324|Incidence|61067428|Brain and Other Nervous System|2013
0-14|~|~|~|~|Mortality|61067428|Hodgkin Lymphoma|2013
0-14|0.5|0.6|0.6|337|Incidence|61067428|Hodgkin Lymphoma|2013
0-14|0.0|0.1|0.1|40|Mortality|61067428|Kidney and Renal Pelvis|2013
0-14|0.8|1.0|0.9|561|Incidence|61067428|Kidney and Renal Pelvis|2013
0-14|0.5|0.6|0.6|350|Mortality|61067428|Leukemia|2013
0-14|4.7|5.1|4.9|2990|Incidence|61067428|Leukemia|2013
0-14|0.0|0.1|0.0|29|Mortality|61067428|Non-Hodgkin Lymphoma|2013
0-14|0.9|1.1|1.0|601|Incidence|61067428|Non-Hodgkin Lymphoma|2013
0-14|0.4|0.5|0.4|254|Mortality|61067428|Other|2013
0-14|4.1|4.4|4.3|2608|Incidence|61067428|Other|2013
0-14|0.1|0.2|0.2|101|Mortality|61067428|Soft Tissue|2013
0-14|1.0|1.2|1.1|668|Incidence|61067428|Soft Tissue|2013
0-19|0.2|0.3|0.2|197|Mortality|82244884|Acute Lymphocytic|2013
0-19|3.1|3.3|3.2|2642|Incidence|82244884|Acute Lymphocytic|2013
0-19|0.2|0.3|0.2|186|Mortality|82244884|Acute Myeloid|2013
0-19|0.7|0.8|0.8|630|Incidence|82244884|Acute Myeloid|2013
0-19|2.2|2.4|2.3|1914|Mortality|82244884|All Cancer Sites Combined|2013
0-19|18.2|18.8|18.5|15270|Incidence|82244884|All Cancer Sites Combined|2013
0-19|0.2|0.3|0.2|180|Mortality|82244884|Bones and Joints|2013
0-19|0.9|1.0|0.9|783|Incidence|82244884|Bones and Joints|2013
0-19|0.6|0.7|0.7|556|Mortality|82244884|Brain and Other Nervous System|2013
0-19|3.3|3.6|3.4|2821|Incidence|82244884|Brain and Other Nervous System|2013
0-19|~|~|~|~|Mortality|82244884|Hodgkin Lymphoma|2013
0-19|1.1|1.2|1.2|964|Incidence|82244884|Hodgkin Lymphoma|2013
0-19|0.0|0.1|0.1|46|Mortality|82244884|Kidney and Renal Pelvis|2013
0-19|0.7|0.8|0.8|618|Incidence|82244884|Kidney and Renal Pelvis|2013
0-19|0.6|0.7|0.6|509|Mortality|82244884|Leukemia|2013
0-19|4.3|4.6|4.4|3632|Incidence|82244884|Leukemia|2013
0-19|0.1|0.1|0.1|60|Mortality|82244884|Non-Hodgkin Lymphoma|2013
0-19|1.1|1.2|1.2|967|Incidence|82244884|Non-Hodgkin Lymphoma|2013
0-19|0.4|0.5|0.4|367|Mortality|82244884|Other|2013
0-19|5.4|5.7|5.6|4599|Incidence|82244884|Other|2013
0-19|0.2|0.3|0.2|183|Mortality|82244884|Soft Tissue|2013
0-19|1.0|1.1|1.1|886|Incidence|82244884|Soft Tissue|2013
0-14|0.2|0.3|0.2|141|Mortality|61053030|Acute Lymphocytic|2014
0-14|3.7|4.0|3.9|2371|Incidence|61053030|Acute Lymphocytic|2014
0-14|0.1|0.2|0.2|94|Mortality|61053030|Acute Myeloid|2014
0-14|0.7|0.8|0.7|448|Incidence|61053030|Acute Myeloid|2014
0-14|1.9|2.1|2.0|1225|Mortality|61053030|All Cancer Sites Combined|2014
0-14|17.3|18.0|17.6|10788|Incidence|61053030|All Cancer Sites Combined|2014
0-14|0.1|0.2|0.1|85|Mortality|61053030|Bones and Joints|2014
0-14|0.7|0.9|0.8|498|Incidence|61053030|Bones and Joints|2014
0-14|0.6|0.8|0.7|420|Mortality|61053030|Brain and Other Nervous System|2014
0-14|3.6|3.9|3.8|2305|Incidence|61053030|Brain and Other Nervous System|2014
0-14|~|~|~|~|Mortality|61053030|Hodgkin Lymphoma|2014
0-14|0.5|0.6|0.6|337|Incidence|61053030|Hodgkin Lymphoma|2014
0-14|0.0|0.1|0.0|24|Mortality|61053030|Kidney and Renal Pelvis|2014
0-14|0.9|1.0|0.9|575|Incidence|61053030|Kidney and Renal Pelvis|2014
0-14|0.4|0.5|0.5|296|Mortality|61053030|Leukemia|2014
0-14|4.8|5.2|5.0|3051|Incidence|61053030|Leukemia|2014
0-14|0.0|0.1|0.1|39|Mortality|61053030|Non-Hodgkin Lymphoma|2014
0-14|1.1|1.2|1.1|698|Incidence|61053030|Non-Hodgkin Lymphoma|2014
0-14|0.4|0.5|0.5|285|Mortality|61053030|Other|2014
0-14|4.2|4.5|4.4|2668|Incidence|61053030|Other|2014
0-14|0.1|0.2|0.1|76|Mortality|61053030|Soft Tissue|2014
0-14|1.0|1.2|1.1|656|Incidence|61053030|Soft Tissue|2014
0-19|0.2|0.3|0.3|207|Mortality|82105856|Acute Lymphocytic|2014
0-19|3.2|3.4|3.3|2725|Incidence|82105856|Acute Lymphocytic|2014
0-19|0.2|0.2|0.2|148|Mortality|82105856|Acute Myeloid|2014
0-19|0.7|0.9|0.8|659|Incidence|82105856|Acute Myeloid|2014
0-19|2.1|2.3|2.2|1837|Mortality|82105856|All Cancer Sites Combined|2014
0-19|18.8|19.4|19.1|15735|Incidence|82105856|All Cancer Sites Combined|2014
0-19|0.2|0.3|0.2|181|Mortality|82105856|Bones and Joints|2014
0-19|0.9|1.0|1.0|796|Incidence|82105856|Bones and Joints|2014
0-19|0.6|0.7|0.7|559|Mortality|82105856|Brain and Other Nervous System|2014
0-19|3.3|3.6|3.4|2816|Incidence|82105856|Brain and Other Nervous System|2014
0-19|~|~|~|~|Mortality|82105856|Hodgkin Lymphoma|2014
0-19|1.1|1.3|1.2|989|Incidence|82105856|Hodgkin Lymphoma|2014
0-19|0.0|0.1|0.0|34|Mortality|82105856|Kidney and Renal Pelvis|2014
0-19|0.7|0.8|0.8|625|Incidence|82105856|Kidney and Renal Pelvis|2014
0-19|0.5|0.6|0.6|456|Mortality|82105856|Leukemia|2014
0-19|4.4|4.7|4.5|3730|Incidence|82105856|Leukemia|2014
0-19|0.1|0.1|0.1|69|Mortality|82105856|Non-Hodgkin Lymphoma|2014
0-19|1.3|1.5|1.4|1142|Incidence|82105856|Non-Hodgkin Lymphoma|2014
0-19|0.4|0.5|0.5|389|Mortality|82105856|Other|2014
0-19|5.6|5.9|5.7|4742|Incidence|82105856|Other|2014
0-19|0.1|0.2|0.2|143|Mortality|82105856|Soft Tissue|2014
0-19|1.0|1.2|1.1|895|Incidence|82105856|Soft Tissue|2014
0-14|0.2|0.2|0.2|673|Mortality|304817554|Acute Lymphocytic|2014-2018
0-14|3.9|4.1|4.0|12138|Incidence|302007630|Acute Lymphocytic|2014-2018
0-14|0.2|0.2|0.2|601|Mortality|304817554|Acute Myeloid|2014-2018
0-14|0.7|0.8|0.7|2179|Incidence|302007630|Acute Myeloid|2014-2018
0-14|2.0|2.1|2.1|6278|Mortality|304817554|All Cancer Sites Combined|2014-2018
0-14|17.3|17.6|17.5|52880|Incidence|302007630|All Cancer Sites Combined|2014-2018
0-14|0.1|0.2|0.1|415|Mortality|304817554|Bones and Joints|2014-2018
0-14|0.8|0.8|0.8|2422|Incidence|302007630|Bones and Joints|2014-2018
0-14|0.7|0.7|0.7|2125|Mortality|304817554|Brain and Other Nervous System|2014-2018
0-14|3.6|3.7|3.6|11007|Incidence|302007630|Brain and Other Nervous System|2014-2018
0-14|~|~|~|~|Mortality|304817554|Hodgkin Lymphoma|2014-2018
0-14|0.6|0.6|0.6|1759|Incidence|302007630|Hodgkin Lymphoma|2014-2018
0-14|0.0|0.1|0.1|177|Mortality|304817554|Kidney and Renal Pelvis|2014-2018
0-14|0.9|0.9|0.9|2756|Incidence|302007630|Kidney and Renal Pelvis|2014-2018
0-14|0.5|0.6|0.5|1602|Mortality|304817554|Leukemia|2014-2018
0-14|5.0|5.2|5.1|15398|Incidence|302007630|Leukemia|2014-2018
0-14|0.0|0.1|0.1|168|Mortality|304817554|Non-Hodgkin Lymphoma|2014-2018
0-14|1.0|1.1|1.1|3204|Incidence|302007630|Non-Hodgkin Lymphoma|2014-2018
0-14|0.4|0.4|0.4|1280|Mortality|304817554|Other|2014-2018
0-14|4.3|4.4|4.4|13191|Incidence|302007630|Other|2014-2018
0-14|0.2|0.2|0.2|501|Mortality|304817554|Soft Tissue|2014-2018
0-14|1.0|1.1|1.0|3143|Incidence|302007630|Soft Tissue|2014-2018
0-19|0.2|0.3|0.2|1008|Mortality|410239928|Acute Lymphocytic|2014-2018
0-19|3.4|3.5|3.4|14007|Incidence|406542905|Acute Lymphocytic|2014-2018
0-19|0.2|0.2|0.2|867|Mortality|410239928|Acute Myeloid|2014-2018
0-19|0.7|0.8|0.8|3107|Incidence|406542905|Acute Myeloid|2014-2018
0-19|2.2|2.3|2.3|9250|Mortality|410239928|All Cancer Sites Combined|2014-2018
0-19|19.0|19.3|19.1|78023|Incidence|406542905|All Cancer Sites Combined|2014-2018
0-19|0.2|0.2|0.2|944|Mortality|410239928|Bones and Joints|2014-2018
0-19|0.9|1.0|1.0|3966|Incidence|406542905|Bones and Joints|2014-2018
0-19|0.6|0.7|0.7|2693|Mortality|410239928|Brain and Other Nervous System|2014-2018
0-19|3.3|3.4|3.3|13428|Incidence|406542905|Brain and Other Nervous System|2014-2018
0-19|0.0|0.0|0.0|46|Mortality|410239928|Hodgkin Lymphoma|2014-2018
0-19|1.2|1.3|1.2|5054|Incidence|406542905|Hodgkin Lymphoma|2014-2018
0-19|0.0|0.1|0.1|226|Mortality|410239928|Kidney and Renal Pelvis|2014-2018
0-19|0.7|0.8|0.7|2992|Incidence|406542905|Kidney and Renal Pelvis|2014-2018
0-19|0.6|0.6|0.6|2364|Mortality|410239928|Leukemia|2014-2018
0-19|4.5|4.7|4.6|18732|Incidence|406542905|Leukemia|2014-2018
0-19|0.1|0.1|0.1|315|Mortality|410239928|Non-Hodgkin Lymphoma|2014-2018
0-19|1.3|1.3|1.3|5262|Incidence|406542905|Non-Hodgkin Lymphoma|2014-2018
0-19|0.4|0.5|0.4|1838|Mortality|410239928|Other|2014-2018
0-19|5.8|6.0|5.9|24203|Incidence|406542905|Other|2014-2018
0-19|0.2|0.2|0.2|824|Mortality|410239928|Soft Tissue|2014-2018
0-19|1.0|1.1|1.1|4386|Incidence|406542905|Soft Tissue|2014-2018
0-14|0.2|0.3|0.2|146|Mortality|60999224|Acute Lymphocytic|2015
0-14|3.9|4.3|4.1|2512|Incidence|60999224|Acute Lymphocytic|2015
0-14|0.2|0.2|0.2|119|Mortality|60999224|Acute Myeloid|2015
0-14|0.7|0.8|0.7|446|Incidence|60999224|Acute Myeloid|2015
0-14|2.0|2.2|2.1|1272|Mortality|60999224|All Cancer Sites Combined|2015
0-14|17.6|18.2|17.9|10938|Incidence|60999224|All Cancer Sites Combined|2015
0-14|0.1|0.2|0.1|84|Mortality|60999224|Bones and Joints|2015
0-14|0.7|0.9|0.8|478|Incidence|60999224|Bones and Joints|2015
0-14|0.6|0.8|0.7|430|Mortality|60999224|Brain and Other Nervous System|2015
0-14|3.5|3.8|3.6|2222|Incidence|60999224|Brain and Other Nervous System|2015
0-14|~|~|~|~|Mortality|60999224|Hodgkin Lymphoma|2015
0-14|0.5|0.7|0.6|362|Incidence|60999224|Hodgkin Lymphoma|2015
0-14|0.0|0.1|0.1|36|Mortality|60999224|Kidney and Renal Pelvis|2015
0-14|0.9|1.1|1.0|609|Incidence|60999224|Kidney and Renal Pelvis|2015
0-14|0.5|0.6|0.6|343|Mortality|60999224|Leukemia|2015
0-14|5.0|5.4|5.2|3177|Incidence|60999224|Leukemia|2015
0-14|0.0|0.1|0.1|35|Mortality|60999224|Non-Hodgkin Lymphoma|2015
0-14|0.9|1.1|1.0|624|Incidence|60999224|Non-Hodgkin Lymphoma|2015
0-14|0.3|0.4|0.4|235|Mortality|60999224|Other|2015
0-14|4.4|4.7|4.6|2800|Incidence|60999224|Other|2015
0-14|0.1|0.2|0.2|105|Mortality|60999224|Soft Tissue|2015
0-14|1.0|1.2|1.1|666|Incidence|60999224|Soft Tissue|2015
0-19|0.2|0.3|0.3|206|Mortality|82080244|Acute Lymphocytic|2015
0-19|3.4|3.7|3.5|2901|Incidence|82080244|Acute Lymphocytic|2015
0-19|0.2|0.2|0.2|175|Mortality|82080244|Acute Myeloid|2015
0-19|0.7|0.8|0.8|636|Incidence|82080244|Acute Myeloid|2015
0-19|2.2|2.4|2.3|1855|Mortality|82080244|All Cancer Sites Combined|2015
0-19|19.3|19.9|19.6|16178|Incidence|82080244|All Cancer Sites Combined|2015
0-19|0.2|0.3|0.2|197|Mortality|82080244|Bones and Joints|2015
0-19|0.9|1.0|1.0|783|Incidence|82080244|Bones and Joints|2015
0-19|0.6|0.7|0.6|531|Mortality|82080244|Brain and Other Nervous System|2015
0-19|3.2|3.5|3.3|2730|Incidence|82080244|Brain and Other Nervous System|2015
0-19|~|~|~|~|Mortality|82080244|Hodgkin Lymphoma|2015
0-19|1.2|1.3|1.2|1032|Incidence|82080244|Hodgkin Lymphoma|2015
0-19|0.0|0.1|0.1|44|Mortality|82080244|Kidney and Renal Pelvis|2015
0-19|0.7|0.9|0.8|662|Incidence|82080244|Kidney and Renal Pelvis|2015
0-19|0.5|0.7|0.6|490|Mortality|82080244|Leukemia|2015
0-19|4.6|4.9|4.7|3876|Incidence|82080244|Leukemia|2015
0-19|0.1|0.1|0.1|73|Mortality|82080244|Non-Hodgkin Lymphoma|2015
0-19|1.2|1.4|1.3|1051|Incidence|82080244|Non-Hodgkin Lymphoma|2015
0-19|0.4|0.5|0.4|350|Mortality|82080244|Other|2015
0-19|6.0|6.3|6.2|5109|Incidence|82080244|Other|2015
0-19|0.2|0.2|0.2|158|Mortality|82080244|Soft Tissue|2015
0-19|1.1|1.2|1.1|935|Incidence|82080244|Soft Tissue|2015
0-14|0.2|0.3|0.2|146|Mortality|60977312|Acute Lymphocytic|2016
0-14|4.0|4.3|4.1|2526|Incidence|60977312|Acute Lymphocytic|2016
0-14|0.2|0.3|0.2|133|Mortality|60977312|Acute Myeloid|2016
0-14|0.7|0.8|0.8|465|Incidence|60977312|Acute Myeloid|2016
0-14|2.1|2.3|2.2|1324|Mortality|60977312|All Cancer Sites Combined|2016
0-14|17.4|18.1|17.7|10843|Incidence|60977312|All Cancer Sites Combined|2016
0-14|0.1|0.2|0.1|82|Mortality|60977312|Bones and Joints|2016
0-14|0.8|0.9|0.8|505|Incidence|60977312|Bones and Joints|2016
0-14|0.7|0.8|0.7|444|Mortality|60977312|Brain and Other Nervous System|2016
0-14|3.5|3.8|3.7|2239|Incidence|60977312|Brain and Other Nervous System|2016
0-14|~|~|~|~|Mortality|60977312|Hodgkin Lymphoma|2016
0-14|0.5|0.6|0.6|354|Incidence|60977312|Hodgkin Lymphoma|2016
0-14|0.0|0.1|0.1|38|Mortality|60977312|Kidney and Renal Pelvis|2016
0-14|0.8|1.0|0.9|545|Incidence|60977312|Kidney and Renal Pelvis|2016
0-14|0.5|0.6|0.6|351|Mortality|60977312|Leukemia|2016
0-14|5.1|5.4|5.3|3218|Incidence|60977312|Leukemia|2016
0-14|0.0|0.1|0.1|31|Mortality|60977312|Non-Hodgkin Lymphoma|2016
0-14|1.0|1.2|1.1|671|Incidence|60977312|Non-Hodgkin Lymphoma|2016
0-14|0.4|0.5|0.4|269|Mortality|60977312|Other|2016
0-14|4.2|4.5|4.4|2669|Incidence|60977312|Other|2016
0-14|0.1|0.2|0.2|107|Mortality|60977312|Soft Tissue|2016
0-14|1.0|1.1|1.0|642|Incidence|60977312|Soft Tissue|2016
0-19|0.2|0.3|0.3|218|Mortality|82106582|Acute Lymphocytic|2016
0-19|3.4|3.7|3.5|2910|Incidence|82106582|Acute Lymphocytic|2016
0-19|0.2|0.3|0.2|179|Mortality|82106582|Acute Myeloid|2016
0-19|0.7|0.9|0.8|659|Incidence|82106582|Acute Myeloid|2016
0-19|2.2|2.4|2.3|1920|Mortality|82106582|All Cancer Sites Combined|2016
0-19|19.2|19.8|19.5|16029|Incidence|82106582|All Cancer Sites Combined|2016
0-19|0.2|0.3|0.2|200|Mortality|82106582|Bones and Joints|2016
0-19|0.9|1.1|1.0|829|Incidence|82106582|Bones and Joints|2016
0-19|0.6|0.7|0.7|552|Mortality|82106582|Brain and Other Nervous System|2016
0-19|3.2|3.4|3.3|2686|Incidence|82106582|Brain and Other Nervous System|2016
0-19|~|~|~|~|Mortality|82106582|Hodgkin Lymphoma|2016
0-19|1.2|1.3|1.3|1042|Incidence|82106582|Hodgkin Lymphoma|2016
0-19|0.0|0.1|0.1|51|Mortality|82106582|Kidney and Renal Pelvis|2016
0-19|0.7|0.8|0.7|592|Incidence|82106582|Kidney and Renal Pelvis|2016
0-19|0.6|0.7|0.6|499|Mortality|82106582|Leukemia|2016
0-19|4.6|4.9|4.7|3896|Incidence|82106582|Leukemia|2016
0-19|0.1|0.1|0.1|60|Mortality|82106582|Non-Hodgkin Lymphoma|2016
0-19|1.2|1.4|1.3|1091|Incidence|82106582|Non-Hodgkin Lymphoma|2016
0-19|0.4|0.5|0.5|385|Mortality|82106582|Other|2016
0-19|5.9|6.2|6.0|4994|Incidence|82106582|Other|2016
0-19|0.2|0.2|0.2|167|Mortality|82106582|Soft Tissue|2016
0-19|1.0|1.2|1.1|899|Incidence|82106582|Soft Tissue|2016
0-14|0.2|0.2|0.2|122|Mortality|60968112|Acute Lymphocytic|2017
0-14|3.7|4.0|3.9|2378|Incidence|60968112|Acute Lymphocytic|2017
0-14|0.2|0.2|0.2|128|Mortality|60968112|Acute Myeloid|2017
0-14|0.6|0.8|0.7|427|Incidence|60968112|Acute Myeloid|2017
0-14|1.9|2.1|2.0|1237|Mortality|60968112|All Cancer Sites Combined|2017
0-14|16.9|17.5|17.2|10518|Incidence|60968112|All Cancer Sites Combined|2017
0-14|0.1|0.1|0.1|67|Mortality|60968112|Bones and Joints|2017
0-14|0.7|0.8|0.8|472|Incidence|60968112|Bones and Joints|2017
0-14|0.6|0.8|0.7|422|Mortality|60968112|Brain and Other Nervous System|2017
0-14|3.6|4.0|3.8|2317|Incidence|60968112|Brain and Other Nervous System|2017
0-14|~|~|~|~|Mortality|60968112|Hodgkin Lymphoma|2017
0-14|0.5|0.6|0.6|354|Incidence|60968112|Hodgkin Lymphoma|2017
0-14|0.0|0.1|0.1|38|Mortality|60968112|Kidney and Renal Pelvis|2017
0-14|0.8|1.0|0.9|537|Incidence|60968112|Kidney and Renal Pelvis|2017
0-14|0.5|0.6|0.5|315|Mortality|60968112|Leukemia|2017
0-14|4.7|5.1|4.9|3014|Incidence|60968112|Leukemia|2017
0-14|0.0|0.1|0.1|34|Mortality|60968112|Non-Hodgkin Lymphoma|2017
0-14|0.9|1.1|1.0|609|Incidence|60968112|Non-Hodgkin Lymphoma|2017
0-14|0.4|0.5|0.4|258|Mortality|60968112|Other|2017
0-14|4.1|4.4|4.2|2591|Incidence|60968112|Other|2017
0-14|0.1|0.2|0.2|102|Mortality|60968112|Soft Tissue|2017
0-14|0.9|1.1|1.0|624|Incidence|60968112|Soft Tissue|2017
0-19|0.2|0.3|0.2|181|Mortality|82062709|Acute Lymphocytic|2017
0-19|3.2|3.4|3.3|2724|Incidence|82062709|Acute Lymphocytic|2017
0-19|0.2|0.3|0.2|187|Mortality|82062709|Acute Myeloid|2017
0-19|0.7|0.8|0.7|599|Incidence|82062709|Acute Myeloid|2017
0-19|2.1|2.3|2.2|1797|Mortality|82062709|All Cancer Sites Combined|2017
0-19|18.5|19.1|18.8|15481|Incidence|82062709|All Cancer Sites Combined|2017
0-19|0.2|0.2|0.2|171|Mortality|82062709|Bones and Joints|2017
0-19|0.9|1.0|1.0|791|Incidence|82062709|Bones and Joints|2017
0-19|0.6|0.7|0.6|519|Mortality|82062709|Brain and Other Nervous System|2017
0-19|3.3|3.6|3.5|2835|Incidence|82062709|Brain and Other Nervous System|2017
0-19|~|~|~|~|Mortality|82062709|Hodgkin Lymphoma|2017
0-19|1.1|1.3|1.2|1013|Incidence|82062709|Hodgkin Lymphoma|2017
0-19|0.0|0.1|0.1|47|Mortality|82062709|Kidney and Renal Pelvis|2017
0-19|0.7|0.8|0.7|580|Incidence|82062709|Kidney and Renal Pelvis|2017
0-19|0.5|0.6|0.6|460|Mortality|82062709|Leukemia|2017
0-19|4.3|4.6|4.4|3643|Incidence|82062709|Leukemia|2017
0-19|0.1|0.1|0.1|58|Mortality|82062709|Non-Hodgkin Lymphoma|2017
0-19|1.2|1.3|1.2|1018|Incidence|82062709|Non-Hodgkin Lymphoma|2017
0-19|0.4|0.5|0.4|368|Mortality|82062709|Other|2017
0-19|5.5|5.9|5.7|4715|Incidence|82062709|Other|2017
0-19|0.2|0.2|0.2|164|Mortality|82062709|Soft Tissue|2017
0-19|1.0|1.2|1.1|886|Incidence|82062709|Soft Tissue|2017
0-14|0.2|0.2|0.2|118|Mortality|60819876|Acute Lymphocytic|2018
0-14|3.9|4.2|4.1|2453|Incidence|60245835|Acute Lymphocytic|2018
0-14|0.2|0.2|0.2|127|Mortality|60819876|Acute Myeloid|2018
0-14|0.6|0.7|0.7|410|Incidence|60245835|Acute Myeloid|2018
0-14|1.9|2.1|2.0|1220|Mortality|60819876|All Cancer Sites Combined|2018
0-14|16.6|17.2|16.9|10194|Incidence|60245835|All Cancer Sites Combined|2018
0-14|0.1|0.2|0.2|97|Mortality|60819876|Bones and Joints|2018
0-14|0.7|0.9|0.8|487|Incidence|60245835|Bones and Joints|2018
0-14|0.6|0.7|0.7|409|Mortality|60819876|Brain and Other Nervous System|2018
0-14|3.2|3.5|3.3|2010|Incidence|60245835|Brain and Other Nervous System|2018
0-14|~|~|~|~|Mortality|60819876|Hodgkin Lymphoma|2018
0-14|0.5|0.7|0.6|361|Incidence|60245835|Hodgkin Lymphoma|2018
0-14|0.0|0.1|0.1|41|Mortality|60819876|Kidney and Renal Pelvis|2018
0-14|0.8|0.9|0.9|520|Incidence|60245835|Kidney and Renal Pelvis|2018
0-14|0.4|0.5|0.5|297|Mortality|60819876|Leukemia|2018
0-14|4.9|5.3|5.1|3076|Incidence|60245835|Leukemia|2018
0-14|0.0|0.1|0.0|29|Mortality|60819876|Non-Hodgkin Lymphoma|2018
0-14|0.9|1.1|1.0|620|Incidence|60245835|Non-Hodgkin Lymphoma|2018
0-14|0.3|0.4|0.4|233|Mortality|60819876|Other|2018
0-14|4.1|4.4|4.2|2546|Incidence|60245835|Other|2018
0-14|0.1|0.2|0.2|111|Mortality|60819876|Soft Tissue|2018
0-14|0.9|1.0|1.0|574|Incidence|60245835|Soft Tissue|2018
0-19|0.2|0.3|0.2|196|Mortality|81884537|Acute Lymphocytic|2018
0-19|3.4|3.7|3.5|2868|Incidence|81129651|Acute Lymphocytic|2018
0-19|0.2|0.3|0.2|178|Mortality|81884537|Acute Myeloid|2018
0-19|0.6|0.8|0.7|574|Incidence|81129651|Acute Myeloid|2018
0-19|2.1|2.3|2.2|1841|Mortality|81884537|All Cancer Sites Combined|2018
0-19|18.4|18.9|18.6|15178|Incidence|81129651|All Cancer Sites Combined|2018
0-19|0.2|0.3|0.2|195|Mortality|81884537|Bones and Joints|2018
0-19|0.9|1.0|1.0|795|Incidence|81129651|Bones and Joints|2018
0-19|0.6|0.7|0.7|532|Mortality|81884537|Brain and Other Nervous System|2018
0-19|2.9|3.2|3.0|2468|Incidence|81129651|Brain and Other Nervous System|2018
0-19|~|~|~|~|Mortality|81884537|Hodgkin Lymphoma|2018
0-19|1.2|1.3|1.2|1013|Incidence|81129651|Hodgkin Lymphoma|2018
0-19|0.0|0.1|0.1|50|Mortality|81884537|Kidney and Renal Pelvis|2018
0-19|0.6|0.8|0.7|565|Incidence|81129651|Kidney and Renal Pelvis|2018
0-19|0.5|0.6|0.6|459|Mortality|81884537|Leukemia|2018
0-19|4.5|4.8|4.6|3755|Incidence|81129651|Leukemia|2018
0-19|0.1|0.1|0.1|55|Mortality|81884537|Non-Hodgkin Lymphoma|2018
0-19|1.1|1.3|1.2|992|Incidence|81129651|Non-Hodgkin Lymphoma|2018
0-19|0.4|0.5|0.4|346|Mortality|81884537|Other|2018
0-19|5.7|6.0|5.9|4796|Incidence|81129651|Other|2018
0-19|0.2|0.3|0.2|192|Mortality|81884537|Soft Tissue|2018
0-19|0.9|1.0|1.0|794|Incidence|81129651|Soft Tissue|2018
